Ticker
GRCECompany Name
GRACE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -13.11M | 0% | $ 0 |
3/31/2025 | $ -14.9M | 0% | $ 0 |
12/31/2024 | $ -14.04M | 0% | $ 0 |
9/30/2024 | $ -11.81M | 0% | $ 0 |
6/30/2024 | $ -9.69M | 0% | $ 0 |
3/31/2024 | $ -12.33M | 0% | $ 0 |
12/31/2023 | $ -13.57M | 0% | $ 0 |
9/30/2023 | $ -15.4M | 0% | $ 0 |
6/30/2023 | $ -16.73M | 0% | $ 0 |
3/31/2023 | $ -15.91M | 0% | $ 0 |
CF - Operations / Revenues
(=) OCF %
OCF % for GRACE THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -18.09M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |